0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Gastrointestinal Endoscopes A Need to Shift From Disinfection to Sterilization? FREE

William A. Rutala, PhD, MPH1,2; David J. Weber, MD, MPH1,2
[+] Author Affiliations
1Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill
2Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill
JAMA. 2014;312(14):1405-1406. doi:10.1001/jama.2014.12559.
Text Size: A A A
Published online

More than 10 million gastrointestinal endoscopic procedures are performed annually in the United States for diagnostic purposes, therapeutic interventions, or both.1 Because gastrointestinal endoscopes contact mucosal surfaces, use of a contaminated endoscope may lead to patient-to-patient transmission of potential pathogens with a subsequent risk of infection.1

In this issue of JAMA, Epstein and colleagues2 report findings from their investigation of a cluster of New Delhi metallo-β-lactamase (NDM)–producing Escherichia coli associated with gastrointestinal endoscopy that occurred from March 2013 to July 2013 in a single hospital in northeastern Illinois. During the 5-month period, 9 patients with positive cultures for NDM-producing E coli were identified, and a case-control study demonstrated that a history of undergoing an endoscopic procedure at this specific hospital was strongly associated with cases of NDM-producing E coli. Cultures obtained from the endoscope used on 5 of the case patients yielded an NDM-producing E coli from the elevator channel. The elevator channel is unique to side-viewing endoscopes, most often used to perform endoscopic retrograde cholangiopancreatography (ERCP). The elevator has a separate channel and provides orientation of catheters, guide wires, and accessories into the endoscopic visual field. This channel is complex in design and may be more difficult to disinfect completely.

The E coli isolate was highly related (>92%) to all case patient isolates by pulsed-field gel electrophoresis. Endoscope reprocessing procedures were reviewed and no lapses were identified. Further, the automated endoscope reprocessor (AER) was functioning correctly and the duodenoscopes were not damaged. The facility notified the 226 patients who had potential exposure to a culture-positive endoscope. Twenty-seven additional case patients were identified by active surveillance who were colonized and had been exposed to a duodenoscope. No additional cases were identified after the hospital changed its endoscope reprocessing from automated high-level disinfection with ortho-phthalaldehyde to gas sterilization with ethylene oxide.

The key concern raised by this study is whether current US endoscope reprocessing guidelines are adequate to ensure a patient-safe gastrointestinal endoscope (one devoid of potential pathogens) or if endoscopes with their long, narrow channels, right-angle turns, difficult to clean and disinfect components, and heavy microbial contamination impossible to reliably high-level disinfect. To examine this concern and offer recommendations, understanding current knowledge on endoscope reprocessing is necessary.

First, endoscopes are semicritical devices, which contact mucous membranes or nonintact skin, and require at least high-level disinfection.3,4 High-level disinfection achieves complete elimination of all microorganisms, except for small numbers of bacterial spores. Because flexible gastrointestinal endoscopic instruments are heat labile, only high-level disinfection with chemical agents or low-temperature sterilization technologies are possible.3 However, no low-temperature sterilization technology is US Food and Drug Administration (FDA)–cleared for gastrointestinal endoscopes such as duodenoscopes.

Second, more health care–associated outbreaks and clusters of infection have been linked to contaminated endoscopes than to any other medical device.3,5 However, until now, these episodes have been traced to deficient practices such as inadequate cleaning, inappropriate disinfection, and damaged endoscopes or flaws in the design of endoscopes or AERs.3 In addition, reprocessing failures have led to patient notifications and blood-borne pathogen testing in dozens of instances.6

Third, evidence-based endoscope reprocessing guidelines have been prepared by professional organizations and the Centers for Disease Control and Prevention (CDC). Although some data have demonstrated that rigorous adherence to these guidelines will result in a patient-safe endoscope,3,4 other data have demonstrated that all of the steps associated with manual endoscope reprocessing are rarely performed and some essential steps (eg, brushing all endoscope channels and components) are commonly skipped.7 Endoscope reprocessing was improved with the use of AERs because most steps were automated.7

Fourth, endemic transmission of infections associated with gastrointestinal endoscopes may be unrecognized due to inadequate surveillance of outpatient procedures, long lag time between colonization and infection, and a low frequency of clinical infection. Additionally, the risk for some procedures might be higher than others in which normally sterile areas are contaminated. In the cluster of cases identified by Epstein et al, the presence of an unusual pathogen (NDM-producing E coli) prompted an investigation and subsequent recognition that duodenoscopes were the source of the case patient isolates.2

Fifth, the margin of safety associated with reprocessing endoscopes is minimal. Endoscopes are heavily contaminated with microbes. The internal channel of gastrointestinal endoscopes may contain 108-10 (8-10 log10) enteric microorganisms.8 The cleaning step in endoscope reprocessing results in a 4 to 6 log10 reduction of microbes and the high-level disinfection step results in another 4 to 6 log10 reduction of mycobacteria, for a total 8 to 12 log10 reduction of microbes.9 Thus, the margin of safety associated with cleaning and high-level disinfection of gastrointestinal endoscopes is minimal (0-2 log10 margin of safety). Therefore, any deviation from proper reprocessing could result in the failure to eliminate contamination with a possibility of subsequent patient-to-patient transmission. This low margin of safety associated with endoscope reprocessing compares with the 17 log10 margin of safety associated with cleaning and sterilization of surgical instruments.10,11

What should be done to ensure the safety of these commonly used devices? The enforcement of best practices including equipment maintenance and routine audits with at least yearly competency testing of staff who use the reprocessing equipment is imperative. But if adherence to regulation is lax, more outbreaks will likely occur. Obtaining additional information on the frequency and level of microbial contamination of endoscopes that have been cleaned and high-level disinfected with strict adherence to current guidelines will be helpful in defining the extent of the problem. If endoscopes are found to be contaminated with potential pathogens (eg, enteric gram-negative bacilli), the clinical effects of such contamination need to be quantified.

In addition, better approaches to assess the effectiveness of cleaning and high-level disinfection are needed. Although microbiological cultures are the gold standard, they cannot be used as a real-time monitoring process. However, based on the study by Epstein et al, it would be reasonable to perform periodic microbiological surveillance of duodenoscopes to assess microbial contamination, although many questions remain. These include the following: (1) What cutoff should be used to define proper disinfection (eg, 0 pathogens or a higher number, such as <10 colony-forming units of enteric pathogens per channel)? (2) What sampling scheme should be used to evaluate gastrointestinal endoscopes (eg, all or a sample of endoscopes)? (3) Is the trigger for further action based on the level or the frequency of contamination (ie, percent of endoscopes contaminated)? (4) What actions should an endoscopy unit undertake if a positive trigger is reached based upon the level or frequency of contamination (ie, patient notification with an offer of blood-borne pathogen testing, ethylene oxide sterilization of positive endoscopes, or ethylene oxide sterilization of all endoscopes)? Real-time monitoring methods need to be developed and validated to assess the risk of infection.

Moreover, adequate resources must be provided by the manufacturers of endoscopes, AERs, high-level disinfectants, and sterilization technologies as well as federal authorities (CDC, FDA, and National Institutes of Health) to design and complete the necessary studies to determine the risks posed by current reprocessing of endoscopes and develop new reprocessing methods and practices. In addition, new endoscope reprocessing technologies need to be developed that reliably result in sterilization of gastrointestinal endoscopes via an FDA-cleared sterilization process, which would greatly improve the margin of safety. Alternatively, development of sterile disposable gastrointestinal endoscopes or a shift to other sterile diagnostic modalities should be considered. Ethylene oxide sterilization, which was used to terminate this cluster of endoscope-related infections,2 is not a long-term satisfactory solution as it has not been FDA-cleared for sterilizing gastrointestinal endoscopes, many hospitals no longer have ethylene oxide, and the sterilization and aeration time is long (12-15 hours).

Finally, clinicians should be encouraged to report and publish cases of infectious diseases related to endoscopy, especially if current reprocessing methods were adhered to, so it can be determined if the report by Epstein et al2 is the tip of the iceberg or an isolated occurrence. If the former, then revision of the endoscope reprocessing guidelines will be necessary to ensure patient safety. However, regardless of when these issues are resolved, endoscopy will remain an important diagnostic and therapeutic modality and should continue to be used while clinicians strictly adhere to current endoscope reprocessing guidelines.3,4

ARTICLE INFORMATION

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

Corresponding Author: William A. Rutala, PhD, MPH, Hospital Epidemiology, Occupational Health and Safety Program, Room 1001 West Wing, University of North Carolina Health Care, Chapel Hill, NC 27514 (brutala@unch.unc.edu).

Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rutala reports consulting for Clorox and Advanced Sterilization Products and receiving an honorarium from 3M. Dr Weber reports consulting for Clorox, receiving grants from the CDC and NIH, and receiving personal fees from Merck and Pfizer.

Additional Contributions: We thank Todd Huntley Baron, MD (University of North Carolina School of Medicine), for his helpful comments. He did not receive compensation for his contribution.

REFERENCES

Weber  DJ.  Managing and preventing exposure events from inappropriately reprocessed endoscopes. Infect Control Hosp Epidemiol. 2012;33(7):657-660.
PubMed   |  Link to Article
Epstein  L, Hunter  JC, Arwady  MA,  et al.  New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. doi:10.1001/jama.2014.12720.
Rutala  WA, Weber  DJ; Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008.http://www.cdc.gov/hicpac/pdf/guidelines/disinfection_nov_2008.pdf. Accessed September 11, 2014.
Petersen  BT, Chennat  J, Cohen  J,  et al.  Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol. 2011;32(6):527-537.
PubMed   |  Link to Article
Kovaleva  J, Peters  FT, van der Mei  HC, Degener  JE.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013;26(2):231-254.
PubMed   |  Link to Article
Rutala  WA, Weber  DJ.  How to assess risk of disease transmission when there is a failure to follow recommended disinfection and sterilization principles. Infect Control Hosp Epidemiol. 2007;28(2):146-155.
PubMed   |  Link to Article
Ofstead  CL, Wetzler  HP, Snyder  AK, Horton  RA.  Endoscope reprocessing methods. Gastroenterol Nurs. 2010;33(4):304-311.
PubMed   |  Link to Article
Roberts  CG. Studies on the bioburden on medical devices and the importance of cleaning. In: Rutala  WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2000:63-69.
Rutala  WA, Weber  DJ.  FDA labeling requirements for disinfection of endoscopes. Infect Control Hosp Epidemiol. 1995;16(4):231-235.
PubMed   |  Link to Article
Rutala  WA, Gergen  MF, Weber  DJ.  Efficacy of a washer-disinfector in eliminating healthcare-associated pathogens from surgical instruments. Infect Control Hosp Epidemiol. 2014;35(7):883-885.
PubMed   |  Link to Article
Favero  MS. Sterility assurance: Concepts for patient safety. In: Rutala  WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare Facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2000:110-125.

Figures

Tables

References

Weber  DJ.  Managing and preventing exposure events from inappropriately reprocessed endoscopes. Infect Control Hosp Epidemiol. 2012;33(7):657-660.
PubMed   |  Link to Article
Epstein  L, Hunter  JC, Arwady  MA,  et al.  New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. doi:10.1001/jama.2014.12720.
Rutala  WA, Weber  DJ; Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities, 2008.http://www.cdc.gov/hicpac/pdf/guidelines/disinfection_nov_2008.pdf. Accessed September 11, 2014.
Petersen  BT, Chennat  J, Cohen  J,  et al.  Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol. 2011;32(6):527-537.
PubMed   |  Link to Article
Kovaleva  J, Peters  FT, van der Mei  HC, Degener  JE.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013;26(2):231-254.
PubMed   |  Link to Article
Rutala  WA, Weber  DJ.  How to assess risk of disease transmission when there is a failure to follow recommended disinfection and sterilization principles. Infect Control Hosp Epidemiol. 2007;28(2):146-155.
PubMed   |  Link to Article
Ofstead  CL, Wetzler  HP, Snyder  AK, Horton  RA.  Endoscope reprocessing methods. Gastroenterol Nurs. 2010;33(4):304-311.
PubMed   |  Link to Article
Roberts  CG. Studies on the bioburden on medical devices and the importance of cleaning. In: Rutala  WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2000:63-69.
Rutala  WA, Weber  DJ.  FDA labeling requirements for disinfection of endoscopes. Infect Control Hosp Epidemiol. 1995;16(4):231-235.
PubMed   |  Link to Article
Rutala  WA, Gergen  MF, Weber  DJ.  Efficacy of a washer-disinfector in eliminating healthcare-associated pathogens from surgical instruments. Infect Control Hosp Epidemiol. 2014;35(7):883-885.
PubMed   |  Link to Article
Favero  MS. Sterility assurance: Concepts for patient safety. In: Rutala  WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare Facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2000:110-125.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

6,063 Views
10 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs